How do I buy Stoke Therapeutics (STOK) stock?

You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.View our list of the best stock brokerages

Who are Stoke Therapeutics (STOK) competitors?

Other companies in Stoke Therapeutics’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Sarepta Therapeutics Inc (NASDAQ:SRPT) and Syndax Pharmaceuticals Inc (NASDAQ:SNDX).

What is the forecast, or price target, for Stoke Therapeutics (STOK) stock?

Stoke Therapeutics has a consensus price target of $31.33.

What is the current price for Stoke Therapeutics (STOK)?

The stock price for Stoke Therapeutics (NASDAQ: STOK) is $34.27 last updated January 9, 2026 at 8:41 AM EST.

Does Stoke Therapeutics (STOK) pay a dividend?

There are no upcoming dividends for Stoke Therapeutics.

When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?

Stoke Therapeutics does not have any upcoming earnings scheduled.

Is Stoke Therapeutics (STOK) going to split?

There is no upcoming split for Stoke Therapeutics.

What sector and industry does Stoke Therapeutics (STOK) operate in?

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Stoke Therapeutics (STOK) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

Comments